8-KFiling Date: Aug 11, 2026

Joby Aviation

Material Agreement, Securities Issuance, Reg FD Disclosure, Other Events, Financial Statements

View SEC Filing
ACC: 0001628280-26-055505

Event Type

Material AgreementSecurities IssuanceReg FD DisclosureOther EventsFinancial Statements
description

Event Description

Item 1.01. Material Agreement
expand_more

On August 8, 2026, Joby Aviation, Inc. entered into a Stock Purchase Agreement with Strix Holdings, Inc. (Target), Strix Parent, LLC (Seller), and certain members of RS Seller Holdco, LLC, to acquire 100% of the Target’s capital stock, which indirectly owns Resonant Sciences, LLC. The base purchase price is $500,000,000, payable in cash except for stock consideration to the Management Members, expected to be approximately $50.0 million, issued at $7.4752 per share of Joby common stock. Closing is subject to conditions including a pre-closing restructuring, regulatory and national security approvals, and absence of a Material Adverse Effect; the agreement may be terminated by mutual consent or by either party if closing does not occur by February 8, 2027, subject to extensions. The Purchase Agreement is filed as Exhibit 2.1 to this Form 8-K and incorporated by reference.

Original SEC Filing Text expand_more
Item 1.01 Entry into a Material Definitive Agreement. On August 8, 2026, Joby Aviation, Inc., (the Company ), entered into a Stock Purchase Agreement (the Purchase Agreement ), by and among the Company, Strix Holdings, Inc., a Delaware corporation (the Target ), Strix Parent, LLC, a Delaware limited liability company (the Seller ), and members of RS Seller Holdco, LLC ( Management Holdco and such members, the Management Members ) (the Management Members collectively with the Seller, the Seller Parties ). The Purchase Agreement provides, among other things, that upon the terms and subject to the satisfaction or waiver of the conditions set forth therein, in exchange for the Purchase Price, the Company will purchase from the Seller Parties, and the Seller Parties will transfer to the Company, one hundred percent (100%) of the issued and outstanding capital stock of the Target, which, through its subsidiaries, owns one hundred percent (100%) of the equity interests of Resonant Sciences, LLC, an Ohio limited liability company ( OpCo and OpCo, together with the Target and its subsidiaries, the Resonant Companies ) (such transaction, the Equity Purchase ). Each capitalized term used herein but not otherwise defined has the meaning given to it in the Purchase Agreement. Pursuant to the terms of, and subject to the conditions specified in, the Purchase Agreement, which has been approved by the board of directors of the Target and the members of Seller, upon the closing of the Equity Purchase (the Closing and the date on which the Closing occurs, the Closing Date ) the Company will pay as consideration for the Equity Purchase $500,000,000 (the Base Purchase Price ), which shall be subject to certain adjustments, including closing cash, closing indebtedness, transaction expenses and net working capital adjustments (the Base Purchase Price, so adjusted, the Purchase Price ). The Purchase Price shall be paid in cash, with the exception of stock consideration payable to the Management Members. The stock consideration payable shall be equal to 40% of the Purchase Price payable to the Management Members (the Stock Purchase Price and such shares issued in connection therewith, the Share Consideration ) and is expected to comprise approximately $50.0 million of the total consideration payable at the Closing. The Share Consideration will comprise shares of the Company s common stock, par value $0.0001 per share (the Common Stock ). The number of shares of Common Stock issued in connection with the Share Consideration shall be equal to the Stock Purchase Price divided by $7.4752, which represents the volume-weighted average price per share of Common Stock on the NYSE as reported by Bloomberg L.P., calculated to four decimal places and determined without regard to afterhours trading or any other trading outside the regular trading session trading hours, for the twenty (20) consecutive Business Days ending on (and including) the Business Day that was two (2) Business Days prior to the date of the Purchase Agreement. The Company intends to issue any shares of Common Stock constituting Share Consideration in reliance upon the exemptions from registration afforded by Section 4(a)(2) or Rule 506 of Regulation D promulgated under the Securities Act of 1933, as amended (the Securities Act ). The Company will file a supplement to the prospectus included in the Company s existing Registration Statement filed on Form S-3 on October 24, 2024 (Registration No. 333-282809), covering the resale of the shares of Common Stock to be issued pursuant to the Purchase Agreement. The obligation of the parties to consummate the transactions contemplated by the Purchase Agreement are subject to the satisfaction or waiver of a number of customary conditions to Closing, including, among others, (a) the completion of a pre-Closing restructuring such that the Seller and the Management Members collectively hold one hundred percent (100%) of the issued and outstanding equity interests of the Target prior to Closing (the Pre-Closing Restructuring ), (b) the receipt of certain specified required regulatory and national security approvals, (c) the absence of any law or order that is in effect which makes illegal, enjoins or otherwise prohibits the consummation of the transactions contemplated by the Purchase Agreement, (d) the representations and warranties made by Seller, on behalf of itself and with respect to the Resonant Companies, and the Company being true and correct, subject to the materiality standards contained in the Purchase Agreement, and the Seller, the Target, and the Company having complied in all material respects with their respective covenants and agreements under the Purchase Agreement, (e) the absence of any Material Adverse Effect with respect to the Resonant Companies, (f) receipt by the Company and Seller of certain agreements and certificates, and (g) that certain agreements entered into as of the signing date have not been repudiated or terminated. Pursuant to the Purchase Agreement, the Seller may neither (a) solicit, facilitate or encourage alternative transaction proposals, (b) enter into, participate in, or maintain discussions or negotiations relating to an alternative transaction proposal, (c) furnish information to any other Person that may reasonably lead to an alternative transaction proposal, nor (d) accept any alternative transaction proposal or enter into any agreement or understanding providing for the consummation of an alternative transaction. The Purchase Agreement can be terminated at any time by the mutual written consent of Seller and the Company. Additionally, the Purchase Agreement can be terminated (a) by either Seller or Company if the Closing shall not have occurred prior to February 8, 2027, subject to certain extensions with respect to obtaining the required regulatory and national security approvals, (b) by either Seller or the Company if (i) any law or order that is in effect which makes illegal, enjoins or otherwise prohibits the consummation of the transactions contemplated by the Purchase Agreement, or (ii) the other party breaches any of its representations, warranties, covenants or agreements in the Purchase Agreement (subject to a cure period of 30 days after written notice thereof) such that the conditions to Closing relating thereto would not be satisfied at the Closing, (c) by the Company if a Material Adverse Effect has occurred, and (d) by Seller if Seller has irrevocably confirmed to the Company that all of Seller s conditions to the Closing have been satisfied and Seller is ready, willing and able to consummate the Equity Purchase, but the Company fails to consummate the Closing in accordance with the terms of the Purchase Agreement. The foregoing description of the Equity Purchase and the Purchase Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Purchase Agreement, which is filed as Exhibit 2.1 to this Current Report on Form 8-K and is incorporated herein by reference. The Purchase Agreement contains representations and warranties of the Company, on the one hand, and of Seller, with respect to itself and with respect to the Resonant Companies, on the other hand, made solely for the benefit of the other party. The assertions embodied in those representations and warranties are qualified by information in confidential disclosure schedules that the parties have exchanged in connection with signing the Purchase Agreement. The disclosure schedules contain information that modifies, qualifies and creates exceptions to the representations and warranties set forth in the Purchase Agreement. Accordingly, investors and securityholders should not rely on the representations and warranties in the Purchase Agreement as characterizations of the actual state of facts or condition of the Target, the Seller, the Company or their respective subsidiaries or affiliates. Moreover, information concerning the subject matter of the representations, warranties and covenants may change after the date of the Purchase Agreement, which subsequent information may or may not be fully reflected in public disclosures. Forward Looking Statements This communication contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to, statements regarding the potential timing and acquisition of the Resonant Companies; the receipt of regulatory approvals and the satisfaction of other closing conditions for the acquisition of the Resonant Companies; the issuance and registration for resale of shares of Common Stock; and the expected benefits of the acquisition of the Resonant Companies. You can identify forward-looking statements by the fact that they do not relate strictly to historical or current facts. These statements may include words such as anticipate , estimate , expect , project , plan , intend , believe , may , will , should , can have , likely and other words and terms of similar meaning in connection with any discussion of the timing or nature of future operating or financial performance or other events. All forward looking statements are subject to risks and uncertainties that may cause actual results to differ materially, including: risks associated with the potential failure to satisfy any closing conditions for the acquisition of the Resonant Companies; our ability to integrate the Resonant Companies business and team into our operations; our ability to retain key personnel; our ability to realize anticipated benefits of any combined operations; risks of unanticipated costs of acquiring or integrating the Resonant Companies business; the potential impact of the announcement or consummation of the proposed acquisition on relationships with third parties, including employees, customers, partners and competitors; and other important factors discussed in the section titled Risk Factors in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the SEC ) on February 27, 2026, our Quarterly Report on Form 10-Q filed with the SEC on May 6, 2026, and in future filings and other reports we file with or furnish to the SEC. Any such forward-looking statements represent management s estimates and beliefs as of the date of this communication. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change.
description

Event Description

Item 3.02. Securities Issuance
expand_more

Item 3.02 incorporates Exhibit 5.1, a legal opinion from Latham & Watkins LLP dated August 11, 2026, relating to Joby Aviation, Inc. The opinion addresses the proposed issuance of up to $750,000,000 of shares of common stock, par value $0.0001 per share, under an equity distribution agreement dated August 11, 2026, among Joby Aviation and Morgan Stanley & Co. LLC, J.P. Morgan Securities LLC, Allen Company LLC, and BofA Securities, Inc. The shares are covered by Registration Statement No. 333-282809 on Form S-3 and a prospectus supplement dated August 11, 2026. The opinion states that, upon completion of the required corporate proceedings and issuance against payment of at least par value, the shares will be duly authorized, validly issued, fully paid, and nonassessable.

Original SEC Filing Text expand_more
Item 3.02 Unregistered Sales of Equity Securities. The information set forth in
attach_file附件展品(1)
EX-5.1exhibit51-8xk.htm4,988 charsexpand_more
EX-5.1 4 exhibit51-8xk.htm EX-5.1 DocumentExhibit 5.1 801 Jefferson Avenue, Suite 300 Redwood City, California 94063 Tel +1.650.328.4600 Fax +1.650.463.2600 www.lw.com FIRM AFFILIATE OFFICES Austin Milan Beijing Munich Boston New York Brussels Orange County Chicago Paris Dubai Riyadh D sseldorf San Diego Frankfurt San Francisco Hamburg Seoul Hong Kong Silicon Valley Houston Singapore London Tel Aviv Los Angeles Tokyo Madrid Washington, D.C. August 11, 2026Joby Aviation, Inc.333 Encinal StreetSanta Cruz, CA 95060 Re Registration Statement on Form S-3 (No. 333-282809) Up to $750,000,000 of shares of common stock, $0.0001 par value per share To the addressee set forth above We have acted as special counsel to Joby Aviation, Inc., a Delaware corporation (the Company ), in connection with the proposed issuance from time to time of shares of common stock of the Company, $0.0001 par value per share (the Common Stock ), having an aggregate offering price of up to $750,000,000 (the Shares ), by the Company pursuant to the equity distribution agreement, dated August 11, 2026 (the Distribution Agreement ) between the Company and Morgan Stanley Co. LLC, J.P. Morgan Securities LLC, Allen Company LLC and BofA Securities, Inc. The Shares are included in a registration statement on Form S-3 under the Securities Act of 1933, as amended (the Act ), filed with the Securities and Exchange Commission (the Commission ) on October 24, 2024 (Registration No. 333-282809) (as amended, the Registration Statement ) and are being offered pursuant to a base prospectus dated October 24, 2024 (the Base Prospectus ) and a prospectus supplement dated August 11, 2026 filed with the Commission pursuant to Rule 424(b) under the Act (together with the Base Prospectus, the Prospectus ). This opinion is being furnished in connection with the requirements of Item 601(b)(5) of Regulation S-K under the Act, and no opinion is expressed herein as to any matter pertaining to the contents of the Registration Statement or the Prospectus, other than as expressly stated herein with respect to the issue of the Shares. As such counsel, we have examined such matters of fact and questions of law as we have considered appropriate for purposes of this letter. With your consent, we have relied upon certificates and other assurances of officers of the Company and others as to factual matters without having independently verified such factual matters. We are opining herein as to the General Corporation Law of the State of Delaware (the DGCL ), and we express no opinion with respect to any other laws. August 11, 2026Page 2 Subject to the foregoing and the other matters set forth herein, it is our opinion that, as of the date hereof upon the completion of all Corporate Proceedings (as defined below) relating to the Shares, when the Shares shall have been duly registered on the books of the transfer agent and registrar therefor in the name or on behalf of the purchasers, and have been issued by the Company against payment therefor (not less than par value) in the circumstances contemplated by the Distribution Agreement, the issuance and sale of the Shares will have been duly authorized by all necessary corporate action of the Company, and the Shares will be validly issued, fully paid and nonassessable. In rendering the foregoing opinion, we have assumed that (i) the Company will comply with all applicable notice requirements regarding uncertificated shares provided in the DGCL (ii) upon the issuance of any of the Shares, the total number of shares of Common Stock issued and outstanding will not exceed the total number of shares of Common Stock that the Company is then authorized to issue under its Certificate of Incorporation and (iii) certain terms of the Shares to be issued by the Company from time to time will be authorized and approved by the board of directors (the Board ) of the Company or one or more committees thereof established by the Board or other person or body designated by the Board having the authority to issue and sell Shares pursuant to the Distribution Agreement in accordance with the DGCL, the certificate of incorporation and the bylaws of the Company and certain resolutions of the Board and one or more committees thereof (with such approvals referred to herein as the Corporate Proceedings ) prior to issuance thereof.This opinion is for your benefit in connection with the Registration Statement and may be relied upon by you and by persons entitled to rely upon it pursuant to the applicable provisions of the Act. We consent to your filing this opinion as an exhibit to the Company s Current Report on Form 8-K dated August 11, 2026 and to the reference to our firm in the Prospectus under the heading Legal Matters. In giving such consent, we do not thereby admit that we are in the category of persons whose consent is required under Section 7 of the Act or the rules and regulations of the Commission thereunder.Sincerely, s Latham Watkins LLP
description

Event Description

Item 7.01. Reg FD Disclosure
expand_more

On August 11, 2026, the Company issued a press release announcing its entry into a Purchase Agreement. The press release is attached as Exhibit 99.1 and furnished under Item 7.01 Regulation FD Disclosure.

Original SEC Filing Text expand_more
Item 7.01 Regulation FD Disclosure. On August 11, 2026, the Company issued a press release announcing the entry into the Purchase Agreement, a copy of which is attached as Exhibit 99.1. The information furnished in this
description

Event Description

Item 8.01. Other Events
expand_more

Item 8.01: On August 11, 2026, Joby Aviation, Inc. entered into an Equity Distribution Agreement with Morgan Stanley & Co. LLC, J.P. Morgan Securities LLC, Allen & Company LLC and BofA Securities, Inc. to offer and sell up to $750 million of its common stock through at-the-market offerings under its Form S-3 shelf registration statement (Reg. No. 333-282809, filed October 24, 2024), with aggregate manager commissions of up to 3.0%. Also on August 11, 2026, the company announced a definitive agreement to acquire defense technology company Resonant Sciences for approximately $500 million, consisting of $450 million in cash and $50 million in Joby common stock, with the transaction expected to close in the first half of 2027. The acquisition is intended to make Resonant Joby’s dedicated defense business and combine Joby’s dual-use aircraft and autonomy technologies with Resonant’s radio frequency, sensing and mission systems capabilities; Resonant reported more than $100 million in trailing-twelve-month revenue, approximately 40% year-over-year growth, and high-teens adjusted EBITDA margins.

Item 9.01: Exhibits include the Equity Distribution Agreement (Exhibit 1.1), the Latham & Watkins LLP legal opinion (Exhibit 5.1), and the August 11, 2026 press release (Exhibit 99.1).

Original SEC Filing Text expand_more
Item 8.01 Other Events. On August 11, 2026, the Company entered into an Equity Distribution Agreement (the Distribution Agreement ) with Morgan Stanley & Co. LLC, J.P. Morgan Securities LLC, Allen & Company LLC and BofA Securities, Inc., as agents and/or principals (each, a Manager , and collectively, the Managers ), under which the Company may offer and sell, from time to time at its sole discretion, up to an aggregate of $750,000,000 of shares of its Common Stock, through or to the Managers (the ATM Offering ), pursuant to the Company s effective shelf registration statement on Form S-3 (Registration No. 333-282809), filed with the SEC on October 24, 2024. The Company will file a prospectus supplement with the SEC on August 11, 2026 in connection with the ATM Offering. Under the terms of the Distribution Agreement, the Managers may sell the Common Stock by any method permitted by law deemed to be an at the market offering as defined in Rule 415 of the Securities Act. The Managers will use commercially reasonable efforts to sell the Common Stock from time to time, based upon instructions from the Company (including any price, time or size limits or other customary parameters or conditions the Company may impose). The Company will pay the Managers a commission rate of up to 3.0% in the aggregate of the gross sales price per share sold under the Distribution Agreement. The Distribution Agreement contains customary representations, warranties and agreements by the Company, indemnification rights and obligations of the Company and the Managers, other obligations of the parties and termination provisions. The representations, warranties and agreements contained in the Distribution Agreement were made only for purposes of such agreement and as of specific dates, were solely for the benefit of the parties thereto and may be subject to limitations agreed upon by the contracting parties to such agreement. The foregoing description of the Distribution Agreement does not purport to be complete and is qualified in its entirety by the full text of the Distribution Agreement, a copy of which is filed as Exhibit 1.1 hereto and is incorporated herein by reference. This Current Report on Form 8-K does not constitute an offer to sell any securities or a solicitation of an offer to buy any securities, which for the ATM Offering is being made only by means of a written prospectus meeting the requirements of Section 10 of the Securities Act, nor shall there be any sale of any securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction. A copy of the opinion of Latham & Watkins LLP regarding the validity of the shares of Common Stock that may be issued and sold pursuant to the Distribution Agreement is filed as Exhibit 5.1 hereto and is incorporated by reference.
attach_file附件展品(1)
EX-99.1exhibit991-8xk.htm13,094 charsexpand_more
EX-99.1 5 exhibit991-8xk.htm EX-99.1 DocumentExhibit 99.1Joby Aviation to acquire defense leader Resonant Sciences, creating a scaled defense growth platform. (Credit Joby Aviation)JOBY AVIATION TO SCALE DEFENSE BUSINESS THROUGH ACQUISITION OF RESONANT SCIENCES Acquisition will significantly expand Joby s defense business by adding a fast-growing company with established programs, classified capabilities and scaled manufacturing operations Upon closing, Resonant will become Joby s dedicated defense business, continuing its existing programs while expanding its portfolio to include Joby s hybrid aircraft and autonomy technologies. Joby s commercial aircraft business will remain focused on its electric air taxi initiatives Combination will create immediate opportunities to unite Joby s dual-use aircraft, propulsion and autonomy technologies with Resonant s radio frequency (RF), sensing and mission systems capabilities as well as its world-leading expertise in low-observability aircraft design Resonant delivered more than $100 million in trailing-twelve-month revenue, representing approximately 40% year-over-year growth, alongside strong adjusted EBITDA generation, driven primarily by long-cycle programs with the U.S. government, prime contractors and next generation defense technology programsSANTA CRUZ, Calif. and DAYTON, Ohio August 11, 2026 Joby Aviation, Inc. (NYSE JOBY) today announced that it has entered into a definitive agreement to acquire Resonant Sciences, a Dayton, Ohio-based defense technology company, for approximately $500 million. The acquisition will represent a significant expansion of Joby s defense business, delivering immediate scale through a rapidly growing and EBITDA-positive business supporting active U.S. national security programs.Resonant also brings classified infrastructure, qualified products, established production operations and longstanding customer relationships, as well as a deeply experienced technical team. By bringing together the companies complementary aerospace engineering capabilities, the combination will create a scaled defense growth platform that accelerates autonomy and expands the applications for Joby s technology.Joby s Dedicated Defense Business UnitUpon closing, Resonant will become Joby s dedicated defense business and continue to operate under the Resonant Sciences name, led by Co-Founder and CEO J. Micah North.Joby s existing defense initiatives, which are built on more than a decade of work with defense and intelligence customers, will be consolidated within the new business unit. These include the development of dual-use turbine-electric and hydrogen-electric aircraft, as well as a dual-use autonomy technology stack. Housing this work within Resonant will allow Joby s commercial aviation organization to maintain its primary focus on certifying, manufacturing, and commercializing its electric air taxi.The combination of Joby and Resonant is also expected to create significant opportunities in adjacent markets. An early focus is expected to be the integration of Joby s dual-use autonomy stack with Resonant s Radio Frequency (RF) sensing and signal-processing capabilities, accelerating the development of software-defined autonomous systems for defense customers. Resonant has built an exceptional business that combines advanced technology, vertically integrated production capabilities and deep customer trust, said JoeBen Bevirt, Founder and CEO of Joby Aviation. The combination will pair Resonant s established capabilities with Joby s globally leading aircraft propulsion technologies, creating a powerful platform for the next phase of Resonant s growth. What makes this combination especially compelling is how closely aligned our teams are. Having worked with Micah and his team for several years, we know that we share a passion for deep technical innovation, a bias toward solving hard problems from first principles and a vertically integrated approach that brings design, engineering, testing and production together under one roof. Demand for advanced defense technology is growing rapidly, and Resonant has built the technology, customer relationships and manufacturing capabilities required to meet it, said J. Micah North, Co-Founder and CEO of Resonant Sciences. Joining Joby gives our team access to additional engineering depth, aircraft platforms, autonomy technology and production expertise, allowing us to move faster for our existing customers and pursue opportunities that neither company could address alone, he added. Resonant s name, leadership, people and commitments to our customers will remain in place. What changes is the scale of what we can build and deliver. A High-Growth Defense BusinessFounded in 2015, Resonant employs approximately 250 people and designs, manufactures and delivers advanced RF and mission systems for U.S. national security customers. The company is also a global leader in low-observability technologies, structures and subsystems, with established capabilities spanning advanced sensing, electronic countermeasures, communications and autonomous systems.That leadership has translated into strong financial performance. Revenue increased approximately 40% year over year to more than $100 million over the last twelve months, and in recent periods the company has operated at high-teens adjusted EBITDA margins. Those margins are expected to expand as production volumes increase and recently awarded programs move into production.This growth is supported by accelerating demand as U.S. defense investment increases across Resonant's core markets. During the first half of 2026, the company secured more than three times the bookings recorded during the same period in 2025, with backlog more than doubling year over year. Resonant is a fast-growing business with strong visibility into future revenue, supported by a growing backlog and accelerating demand across its core defense markets, said Rodrigo Brumana, Chief Financial Officer of Joby Aviation. It generates healthy adjusted EBITDA margins, and its technology, customer relationships and scaled manufacturing make it a strong strategic fit for Joby as we build out our defense business. Established Programs and Production at ScaleIn addition to commercial customers, Resonant sells directly to the U.S. Government and leading prime contractors supporting classified national security initiatives and active U.S. defense programs of record. Resonant supports sensitive and critical defense programs via its long-standing Facility Security Clearance (FCL) and accredited facilities, with more than 90 percent of its team members holding security clearances, providing the cleared technical workforce and infrastructure required to execute sensitive programs at scale.Beyond developing RF hardware, Resonant performs end-to-end payload integration and aircraft modification. Its electronics, apertures and radomes are qualified across more than 20 commercial and defense airframes.The capabilities of the two companies are highly applicable to the defense sector s next generation platforms, which reflect a broader shift in defense priorities toward autonomous, lower-cost aircraft, for which advanced sensing, electronic countermeasures and resilient communications are central to mission effectiveness. Resonant already holds content positions across multiple next generation platforms and the companies see meaningful potential to deliver differentiated mission systems and platform solutions for next generation requirements and programs.Resonant operates approximately 105,000 square feet of engineering, integration, testing and manufacturing space across seven buildings in the Dayton, Ohio, area. An additional 125,000-square-foot facility is under construction, more than doubling its footprint and expanding capacity for RF testing, advanced composites and large-scale machining. Resonant also has engineering and manufacturing facilities in Virginia, West Virginia, Michigan, Colorado and North Carolina. Together with Joby s 768,000 square feet of facilities in Ohio, Resonant s expanded campus will give the combined company approximately 1 million square feet of manufacturing, integration and testing space across the Dayton region. This concentration of capabilities will establish a major hub for advanced aviation and defense technology in the birthplace of aviation, helping attract top-tier aerospace talent and industry partners to the region.Transaction DetailsThe transaction is expected to close in the first half of 2027, subject to customary closing conditions, including applicable regulatory reviews. Joby expects to fund the transaction with approximately $450 million in cash and $50 million in Joby common stock. The price per share for the common stock consideration was fixed at signing. Certain Resonant employee stockholders will receive a portion of their consideration in shares of Joby common stock, retaining an ongoing economic interest in the combined company.A recorded message from JoeBen Bevirt, Joby s founder and CEO, discussing the transaction is available on demand through Joby s investor relations website at ir.jobyaviation.com, along with a slide presentation with an overview of today s news. Additional perspective on the transaction is available in a blog post here.About Joby AviationJoby Aviation, Inc. (NYSE JOBY) is a next-generation aviation company based in California, developing an all-electric, vertical take-off and landing air taxi. Its aircraft, propulsion and autonomy technologies span both commercial aviation and defense applications. Joby also operates Blade, a leading urban air mobility business providing passenger transportation services in the United States and Europe. Joby intends to operate its fast, quiet and convenient air taxi service in cities around the world and sell its aircraft to other operators and partners. To learn more, visit www.jobyaviation.com.About Resonant SciencesResonant Sciences is an integrated system supplier focused on radomes, antenna design and fabrication, custom electronic solutions mission systems, RF EO IR modeling, and measurements of materials, antennas, radomes, subsystems, and vehicles. The company supports US Government programs and the broader defense supply chain.Forward-Looking StatementsThis release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to, statements regarding the expected integration, benefits and opportunities of the acquisition of Resonant Sciences the potential timing and acquisition of Resonant Sciences the receipt of regulatory approvals and the satisfaction of other closing conditions for the acquisition of Resonant Sciences the issuance of shares of our common stock as consideration in the acquisition of Resonant Sciences our current expectations relating to our business, financial condition, results of operations, prospects, capital needs and growth of our operations, including our use of cash and expectations regarding the financial performance of Resonant Sciences, including with respect to adjusted EBITDA, cash flows and EBITDA. You can identify forward-looking statements by the fact that they do not relate strictly to historical or current facts. These statements may include words such as anticipate , estimate , expect , project , plan , intend , believe , may , will , should , can have , likely and other words and terms of similar meaning in connection with any discussion of the timing or nature of future operating or financial performance or other events. All forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially, including risks associated with the potential failure to satisfy any closing conditions for the acquisition of Resonant Sciences our ability to integrate Resonant Sciences business and team into our operations and our ability to retain key personnel our ability to realize anticipated benefits of any combined operations risks of unanticipated costs of acquiring or integrating Resonant Sciences business the potential impact of the announcement or consummation of the proposed acquisition on relationships with third parties, including employees, customers, partners and competitors and other important factors discussed in the section titled Risk Factors in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the SEC ) on February 27, 2026, our Quarterly Report on Form 10-Q filed with the SEC on May 5, 2026, and in future filings and other reports we file with or furnish to the SEC. Any such forward-looking statements represent management s estimates and beliefs as of the date of this release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change.Joby Media press jobyaviation.com Joby Investors investors jobyaviation.com
description

Event Description

Item 9.01. Financial Statements
expand_more

Item 9.01 lists exhibits to the 8-K: an Equity Distribution Agreement dated August 11, 2026, among Joby Aviation, Morgan Stanley & Co. LLC, J.P. Morgan Securities LLC, Allen & Company LLC, and BofA Securities, Inc.; a Stock Purchase Agreement dated August 8, 2026, among Joby Aviation, Inc., Strix Holdings, Inc., Strix Parent, LLC, and the Management Members, with schedules omitted and certain portions redacted; an Opinion of Latham & Watkins LLP; its consent included in Exhibit 5.1; a press release dated August 11, 2026; and a Cover Page Interactive Data File. The report is signed by Rodrigo Brumana, Chief Financial Officer of Joby Aviation, Inc., on August 11, 2026.

Original SEC Filing Text expand_more
Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Exhibit Description 1.1 Equity Distribution Agreement, dated as of August 11 , 2026, by and among the Company, Morgan Stanley & Co. LLC, J.P. Morgan Securities LLC, Allen & Company LLC and BofA Securities, Inc. 2.1*# Stock Purchase Agreement, dated August 8 , 2026, by and among Joby Aviation, Inc., Strix Holdings, Inc., Strix Parent, LLC and the Management Members 5.1 Opinion of Latham & Watkins LLP 23.1 Consent of Latham & Watkins LLP (included in Exhibit 5.1) 99.1 Press release issued on August 11, 2026 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). * The schedules to the Stock Purchase Agreement have been omitted from this filing pursuant to Item 601(a)(5) of Regulation S-K. Registrant will furnish copies of such schedules to the SEC upon request by the SEC. # Certain portions of this exhibit (indicated by [***] ) have been omitted pursuant to Regulation #S-K, Item 601(b)(10). SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Joby Aviation, Inc. Date: August 11, 2026 By: /s/ Rodrigo Brumana Name: Rodrigo Brumana Title: Chief Financial Officer

keid analysis is for reference only and does not constitute investment advice.